Search

Search Results
Results 331 - 340 of 347 for Gastrointestinal
  • Pyralin EN
    Drug - 30 Mar 2023
    Consumer Medicine Information (CMI) about Pyralin EN intended for persons living in Australia.
  • Salazopyrin
    Drug - 30 Mar 2023
    Consumer Medicine Information (CMI) about Salazopyrin intended for persons living in Australia.
  • Somavert
    Drug - 31 Jan 2023
    Consumer Medicine Information (CMI) about Somavert intended for persons living in Australia.
  • Abacavir/Lamivudine Viatris
    Drug - 12 Jan 2023
    Consumer Medicine Information (CMI) about Abacavir/Lamivudine Viatris intended for persons living in Australia.
  • Imatinib-Teva
    Drug - 9 Jan 2023
    Consumer Medicine Information (CMI) about Imatinib-Teva intended for persons living in Australia.
  • Telzir Tablets
    Drug - 23 Dec 2022
    Consumer Medicine Information (CMI) about Telzir Tablets intended for persons living in Australia.
  • Tetrabenazine
    Drug - 16 Nov 2022
    Consumer Medicine Information (CMI) about Tetrabenazine intended for persons living in Australia.
  • Jinarc
    Drug - 4 Nov 2022
    Consumer Medicine Information (CMI) about Jinarc intended for persons living in Australia.
  • Agrylin
    Drug - 23 Sep 2022
    Consumer Medicine Information (CMI) about Agrylin intended for persons living in Australia.
  • Prexum Combi
    Drug - 20 Jul 2022
    Consumer Medicine Information (CMI) about Prexum Combi (perindopril and indapamide) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback